199678-10-9

Basic information

• Product Name: 4-(4-(Carboxypyridin-3-yl)benzoic acid
• Synonyms: 4-(4-(Carboxypyridin-3-yl)benzoic acid;4-(4-(Methoxycarbonyl)pyridin-3-yl)benzoic acid;4-(4-Carbamoylpyridin-3-yl)benzoic acid;4-(4-Methylpyridin-3-yl)benzoic acid;4-(5-(Methoxycarbonyl)pyridin-3-yl)benzoic acid;4-(5-Carbamoylpyridin-3-yl)benzoic acid;4-(5-Carboxypyridin-3-yl)ben;4-(6-(Methoxycarbonyl)pyridin-3-yl)benzoic acid
• CAS NO: 199678-10-9
• Molecular Formula: C₁₃H₁₁NO₂
• Molecular Weight: 213.23
• Mol File: 199678-10-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-(Carboxypyridin-3-yl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-(Carboxypyridin-3-yl)benzoic acid(199678-10-9)
• EPA Substance Registry System: 4-(4-(Carboxypyridin-3-yl)benzoic acid(199678-10-9)

Safety Data

• Hazardous Substances Data: 199678-10-9(Hazardous Substances Data)

Upstream product

• 106-38-7 para-bromotoluene 
• 5720-05-8 4-methylphenylboronic acid 
• 3430-13-5 5-bromo-2-methylpyridine 
• 14047-29-1 4-carboxyphenylboronic acid 
• 40881-45-6 4-tolylboronic dimethyl ester 

Relevant articles and documents

A Arylheterocycle chirality bcr - abl inhibitor and its preparation method and application

The invention discloses aromatic heterocyclic biphenyl Bcr-Abl inhibitors as well as a preparation method and application thereof. A structural formula of the inhibitors is shown in the specification, wherein in the structural formula, Ar is aromatic heterocycle; R is a mono-substituent or a di-substituent, and the substituent is alkyl or halogen. The series of inhibitors have a certain inhibiting effect on ABL1 kinase in vitro, can inhibit tumor cell proliferation and can be used for preparing antitumor drugs, especially CML (chronic myelocytic leukemia) drugs. The preparation method of the aromatic heterocyclic biphenyl Bcr-Abl inhibitors, which is provided by the invention, has the advantages of easiness in obtainment of raw materials, mild reaction conditions, simplicity in operation of reaction processes and cheap used reagents.

PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43)

The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.